ACI-Pittsburgh Program Registration
This program has already taken place, to find information on upcoming programs, please check here.Program Agenda
December 15, 2018 ProgramCredit information to be announced. Click here for more detailed CME, CNE and CPE information and program objectives.
Presentations include time for Audience Response System (ARS)-assisted audience interaction as well as general question and answer time.
7:00 – 8:00 a.m.
Check-in, Onsite Registration and Networking
Session I: Introduction to Cancer Immunotherapy
8:00 – 8:05 a.m.
Welcome, Introduction, SITC Resources
8:05 – 8:35 a.m.
Basic Principles of Cancer ImmunotherapyGreg M. Delgoffe, MD – University of Pittsburgh
8:35 – 8:40 a.m.
Session II: Immunotherapy in Practice
Concurrent Session 1
8:40 – 9:20 a.m.
Immunotherapy for the Treatment of Lung CancerAntoinette Wozniak, MD – University of Pittsburgh
Immunotherapy for the Treatment of MelanomaSanjiv S. Agarwala, MD – St. Luke's Cancer Center and Temple University
9:20 – 9:25 a.m.
Concurrent Session 2
9:25 – 10:05 a.m.
Immunotherapy for the Treatment of Head and Neck CancerDan P. Zandberg, MD – UPMC Hillman Cancer Center
Immunotherapy for the Treatment of Genitourinary MalignanciesLeonard J. Appleman, MD, PhD – UPMC Hillman Cancer Center
10:05 – 10:10 a.m.
Joint Session (all attendees)
10:10 – 10:50 a.m.
Immunotherapy for the Treatment of Hematologic MalignanciesJacqueline S. Garcia, MD – Dana-Farber Cancer Institute
Session III: Barriers in Practice
11:20 – Noon
Practical Barriers in Cancer Immunotherapy TreatmentAmy Schippers, PA-C – St. Luke's University & Health Network, St. Luke's Cancer CenterPanel Peter Ellis, MD – UPMC Hillman Cancer CenterAmy Schippers, PA-C – St. Luke's University & Health Network, St. Luke's Cancer Center
Conclusion of Accredited ProgramPlease see updated credit information for this program below.
Unaccredited Session: The Future of Cancer Immunotherapy
12:15 – 12:40 p.m.
What’s Next for Cancer Immunotherapy?Dario A.A. Vignali, PhD – University of Pittsburgh
Updated Credit Information for ACI-Pittsburgh:
The Postgraduate Institute for Medicine designates this live activity for a maximum of 3.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The maximum number of hours awarded for this Continuing Nursing Education activity is 3.0 contact hours. Designated for 2.9 contact hours of pharmacotherapy credit for Advance Practice Registered Nurses.
Postgraduate Institute for Medicine designates this continuing education activity for 3.00 contact hour(s) (0.3 CEUs) of the Accreditation Council for Pharmacy Education.Universal Activity Numbers: JA4008162-9999-18-468-L01-P (S1, S2; Application, 2.5 hours)
JA4008162-9999-18-469-L04-P (S3; Knowledge; 0.5 hours)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Specifically designed by the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, nurse practitioners, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) programs are introductory, CE- and MOC-accredited programs. Presented by leading and local authorities in tumor immunology and cancer immunotherapy, these 4 hour long programs will facilitate understanding of:
Attendees will also have an opportunity for connecting with regional experts in the immunotherapy field at the live event, through four quarterly webinars, and indefinitely through a dedicated online community forum. These connections will serve as ongoing resources while clinical oncologists and other healthcare providers incorporate immunotherapy into practice.
For more information, including program objectives, click here.
View the SITC Meeting Code of Conduct.
The 2018-2019 Advances in Cancer Immunotherapy™ series is brought to you in collaboration with the American Academy of Emergency Medicine, the Association of Community Cancer Centers and the Hematology/Oncology Pharmacy Association.
Download PDF Flyer
Marriott Pittsburgh City Center112 Washington PlacePittsburgh, PA 15219
Participation in this free online pre-program course is strongly recommended as it contains information that will not be covered at the program on December 15, 2018.
This updated, interactive course provides foundational knowledge that is necessary for understanding cancer immunotherapy content that will be discussed at the in-person program. Upon completion of the course, participants can earn continuing education credits (CME, CNE and CPE credits are available).
Click here to access this free course.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com